The More Things Change, The More They Stay The Same
Not much changed in 2017 for investors into pure graphene companies. Disappointing if one was looking forward to breakthroughs in cost-effective mass manufacturing techniques to meet the hype about its use in batteries, retail and industrial products, water distribution and energy efficiencies, military, and medical devices. This is a projection graph from 2013 when Lloyd Blankfein told everyone graphene IPOs are alive and well but will be stuck in the R&D stage for quite a while.
There were announcements about patent application filings, reports of